CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 298 enrolled
Drug / intervention
Radiofrequency Ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04673032
NCT04673032N/ACompleted
CompareCT.gov

Radiofrequency (RF) Ablation Prospective Outcomes Study

Boston Scientific Corporation·observational·Posted Dec 17, 2020·Updated Apr 15, 2026

In Brief

An observational study evaluating Radiofrequency Ablation for Pain, Chronic. Completed, enrolled 298 participants across 15 sites in 4 countries.

Detailed Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Chronic
CountriesBelgium, Italy, Netherlands, United States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 17, 2020
Enrollment StartDec 22, 2020
Primary CompletionFeb 7, 2025
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 5.5 years ago

Interventions

Radiofrequency Ablationdevice

Radiofrequency Ablation for treatment of chronic pain